Literature DB >> 1798423

Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews.

J Chapman1, A D Korczyn.   

Abstract

The cluster of Creutzfeldt-Jakob disease (CJD) among Jews of Libyan origin is one of the largest in the world. A number of hypotheses have been proposed to account for this cluster, the most prevalent but unsubstantiated hypothesis being that a transmissible agent was ingested in the form of scrapie-infected sheep brains. It has, however, been shown that a modified host protein encoded by the gene specifying the scrapie amyloid precursor is critically involved in the pathogenesis of transmissible spongiform encephalopathies such as CJD, Gerstmann-Strüssler-Scheinker syndrome and Kuru. A mutation at codon 200 in the open reading frame of this gene has recently been linked to a cluster of CJD patients in Slovakia. We examined the prevalence of this mutation among CJD patients of Libyan descent in Israel. All patients were found to have the same codon 200 mutation. These findings implicate this mutation in the high prevalence of CJD among Libyan Jews and Sephardic Jews from other Mediterranean countries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1798423     DOI: 10.1159/000110276

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  3 in total

Review 1.  Creutzfeldt-Jakob disease among Libyan Jews.

Authors:  A D Korczyn
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

2.  Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.

Authors:  Zeev Meiner; Esther Kahana; Fanny Baitcher; Amos D Korczyn; Joab Chapman; Oren S Cohen; Ron Milo; Judith Aharon-Perez; Oded Abramsky; Ruth Gabizon; Hanna Rosenmann
Journal:  J Neurol       Date:  2010-09-09       Impact factor: 4.849

3.  Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation.

Authors:  J Chapman; P Brown; L G Goldfarb; A Arlazoroff; D C Gajdusek; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.